FDA Adverse Event Malfunction Summary report: N

NI

MDR report key: 8977296 · Received September 9, 2019

Report

Report Number
1416980-2019-04917
Event Type
Malfunction
Date Received
September 9, 2019
Report Date
September 26, 2019
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
FPA
PMA / PMN Number
NI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 0

CORRECTION: PATIENT IDENTIFIERS AND DEMOGRAPHICS (REMOVE N/A, ADD NI), PATIENT/HEALTH/DEVICE CODES (REMOVE 2645, 1371, ADD 2199, 1171, 435). EVENT CORRECTIONS: REMOVE ¿TWO (2) UNKNOWN ACCESS SETS WOULD NOT CONNECT FROM THE TUBING TO THE INTRAVENOUS HUB. IT WAS FURTHER REPORTED THAT MULTIPLE ATTEMPTS WERE MADE TO PUNCTURE WHEN SPIKING AN UNSPECIFIED ANTIBIOTIC. THIS WAS IDENTIFIED DURING PREPARATION. THERE WAS NO PATIENT INVOLVEMENT¿. CHANGE EVENT TO: AN UNSPECIFIED QUANTITY OF ACCESS SETS WERE DIFFICULT TO CONNECT TO THE IV (INTRAVENOUS) HUB AND BECAME DISCONNECTED MULTIPLE TIMES. THIS WAS IDENTIFIED DURING AN UNSPECIFIED PROCESS STEP. THERE WAS NO REPORT OF PATIENT INJURY OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. THE DEVICE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(6). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED TWO (2) UNKNOWN ACCESS SETS WOULD NOT CONNECT FROM THE TUBING TO THE INTRAVENOUS HUB. IT WAS FURTHER REPORTED THAT MULTIPLE ATTEMPTS WERE MADE TO PUNCTURE WHEN SPIKING AN UNSPECIFIED ANTIBIOTIC. THIS WAS IDENTIFIED DURING PREPARATION. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
770445 NI SET, ADMINISTRATION, INTRAVASCULAR FPA BAXTER HEALTHCARE CORPORATION NA ASKU

Patients

Seq Age Sex Outcome Treatment
1